Work

The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins

Year: 2017

Type: article

Source: Current Pharmaceutical Design

DOI: 10.2174/1381612823666170125154257

Authors: Vasilios G. Athyros, Konstantinos Tziomalos, Michael Doumas, George Sfikas, Asterios Karagiannis

Institutions: Aristotle University of Thessaloniki, Ippokrateio General Hospital of Thessaloniki, AHEPA University Hospital, United States Department of Veterans Affairs, George Washington University, Washington DC VA Medical Center, 424 General Military Hospital

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2584428874

FWCI: 1.249

Cites:

Cited by: 7

Related to: 10